# RAD BioMed Accelerator

> RAD BioMed Accelerator is a VC fund backing Health Care and Medical Device. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 4
- Last investment: May 2025
- Lead investor: 25%
- Last updated: Aug 2026
- X (Twitter): http://twitter.com/Radbiomed1
- Website: http://www.radbiomed.com
- Facebook: http://www.facebook.com/RADBioMed

RAD BioMed Accelerator is a venture capital firm that funds life sciences companies based in Israel.

## Contacts

5 contacts available for RAD BioMed Accelerator. Shizune tracks 2 team members at RAD BioMed Accelerator. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/rad-biomed-accelerator?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Medical Device | 3 | 75% |
| Laser | 1 | 25% |
| Medical | 1 | 25% |
| Women's | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yehuda Zisapel | co-founder | 7 | https://shizune.co/investors/profile/yehuda-zisapel |
| David Zigdon | President & CEO | 0 | https://shizune.co/investors/profile/david-zigdon |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| FEMSelect | FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. |  | Series B | May 13, 2025 |  |
| FEMSelect | FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | $9M | Series B | Oct 19, 2022 |  |
| CVAid Medical | CVAid Medical develops an innovative AI based stroke detection technological platform. | $4M | Series A | Feb 23, 2022 |  |
| BELKIN Vision | BELKIN Vision develops a laser device to assist healthcare professionals in treating glaucoma. It offers non-invasive, non-contact, instantaneous, painless, and automated devices offering laser therapy and is aimed at promoting accessibility to first-line drop-less glaucoma care by allowing any ophthalmologist to treat patients. | $6.6M | Series A | Jun 05, 2017 |  |

4 of 4 investments shown.

## Co-investors
- [New Age Ventures](https://shizune.co/investors/profile/new-age-ventures) — VC Fund, 2 deals together
- [Robin Hood Ventures](https://shizune.co/investors/profile/robin-hood-ventures) — VC Fund, 2 deals together
- [Triventures](https://shizune.co/investors/profile/triniventures) — VC Fund, 2 deals together
- [Avea ventures](https://shizune.co/investors/profile/avea-ventures) — VC Fund, 1 deal together
- [European Union](https://shizune.co/investors/profile/european-union) — VC Fund, 1 deal together
- [Keiretsu Capital](https://shizune.co/investors/profile/keiretsu-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does RAD BioMed Accelerator invest in?

RAD BioMed Accelerator invests primarily in Health Care, Medical Device and Laser startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact RAD BioMed Accelerator?

Public channels for RAD BioMed Accelerator include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at RAD BioMed Accelerator?

The team at RAD BioMed Accelerator includes Yehuda Zisapel (co-founder) and David Zigdon (President & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co